// App-Quantinova.ai

TP14 2016 ASA : Final Infarct Volume as an Early Indicator the Clinical Outcome: Insight from ESCAPE Trial

Researchers

Presenter

  • Mayank Goyal

Principal Investigators

  • Biggya Sapkota

  • Cheemun Lum

  • Donald F Frei

  • Walter J Montanera

  • Alexandre Y Poppe

  • Frank L Silver

  • Ashfaq Shuaib

  • Donatella Tampieri

  • David Williams

  • Oh Young Bang

  • Andrew M Demchuk

  • Blaise W Baxter

  • Paul A Burns

  • Hana Choe

  • Ji-Hoe Heo

  • Christine A Holmstedt

  • Brian Jankowitz

  • Michael Kelly

  • Guillermo Linares

  • Michael D Hill

  • Muneer Eesa

  • Jeremy L Rempel

  • John Thornton

  • Daniel Roy

  • Tudor G Jovin

  • Robert A Willinsky

Medical Centers

  • Univ of Calgary, Calgary, Canada

  • Beaumont Hospital, RCSI, Dublin, Ireland

  • Royal Hospitals, Belfast, United Kingdom

  • Swedish Med Cntr, Englewood, CO

  • University of Montreal, Montreal, QC, Canada

  • Drexel University, Philadelphia, PA

  • University of Saskatchewan, Saskatoon, SK, Canada

  • Abington Memorial Hospital, Abington, PA

  • MUSC, Charleston, SC

  • Erlanger Hosp, Chattanooga, TN

  • UPMC, Pittsburgh, PA

  • McGill, Montreal, QC, Canada

  • Univ of Ottawa, Ottawa, Canada

  • U Toronto, Toronto, ON, Canada

  • Royal College of Surgeons in Ireland, Dublin, Ireland

  • Univ. of Alberta, Edmonton, Alberta, Canada.

Locations

  • Ireland

  • Canada

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Central Nervous System (CNS)

Disease

  • Ischemic stroke

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • open label

  • randomized

  • double blind/blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved